Subclinical cardiovascular disease in older adults: insights from the Cardiovascular Health Study
- PMID: 15133417
- DOI: 10.1111/j.1076-7460.2004.02120.x
Subclinical cardiovascular disease in older adults: insights from the Cardiovascular Health Study
Abstract
Knowledge about the epidemiology of subclinical cardiovascular disease (SCVD) in older adults may hold the key for improved opportunities for primary prevention of cardiovascular disease (CVD), a top clinical and public health priority. This review reports findings on the prevalence of SCVD and the ability of SCVD measures to predict incident and adverse outcomes from one of the largest (N=5888) and most comprehensive prospective observational studies on SCVD in older adults, the Cardiovascular Health Study. According to a composite index that combined SCVD measures from different vascular beds, the overall prevalence of SCVD was 37%, making it as common as clinically overt CVD in older adults. SCVD measures strongly predicted incident CVD, stroke, mortality, frailty, and physical and cognitive decline, even after adjustment for traditional CVD risk factors. Ongoing research will address the potential use of SCVD for clinical decision making in older adults.
Similar articles
-
Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults.Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1674-9. doi: 10.1161/01.atv.0000033540.89672.24. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377748
-
Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis.J Am Heart Assoc. 2017 Mar 20;6(3):e004894. doi: 10.1161/JAHA.116.004894. J Am Heart Assoc. 2017. PMID: 28320747 Free PMC article.
-
Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.J Am Geriatr Soc. 2000 Feb;48(2):115-23. doi: 10.1111/j.1532-5415.2000.tb03901.x. J Am Geriatr Soc. 2000. PMID: 10682939
-
Subclinical Cerebrovascular Disease: Epidemiology and Treatment.Curr Atheroscler Rep. 2019 Jul 27;21(10):39. doi: 10.1007/s11883-019-0799-1. Curr Atheroscler Rep. 2019. PMID: 31350593 Free PMC article. Review.
-
Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease.Am J Cardiovasc Drugs. 2015 Jun;15(3):163-70. doi: 10.1007/s40256-015-0114-7. Am J Cardiovasc Drugs. 2015. PMID: 25894618 Review.
Cited by
-
The recent advances, drawbacks, and the future directions of CMRI in the diagnosis of IHD.Sci Rep. 2021 Jul 22;11(1):14958. doi: 10.1038/s41598-021-94311-4. Sci Rep. 2021. PMID: 34294777 Free PMC article.
-
Is aggressive lipid-lowering effective and safe in the older adult?Clin Cardiol. 2005 Sep;28(9):404-7. doi: 10.1002/clc.4960280904. Clin Cardiol. 2005. PMID: 16250262 Free PMC article. Review.
-
Association between osteosarcopenia and coronary artery calcification in asymptomatic individuals.Sci Rep. 2022 Apr 4;12(1):2231. doi: 10.1038/s41598-021-02640-1. Sci Rep. 2022. PMID: 35379833 Free PMC article.
-
Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the cardiovascular health study.Atherosclerosis. 2008 Apr;197(2):768-76. doi: 10.1016/j.atherosclerosis.2007.07.013. Epub 2007 Aug 21. Atherosclerosis. 2008. PMID: 17714717 Free PMC article.
-
Noninvasive assessment of preclinical atherosclerosis.Vasc Health Risk Manag. 2006;2(1):19-30. doi: 10.2147/vhrm.2006.2.1.19. Vasc Health Risk Manag. 2006. PMID: 17319466 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources